Master Class

Gestational diabetes and the Barker Hypothesis


 

References

Although there are some glimmers of hope that U.S. birthweights may be declining, the average infant birthweight has remained significantly tilted toward obesity. Moreover, and alarming number of infants, children, and adolescents are obese.

In 2007-2008, 9.5% of infants and toddlers were at or above the 95th percentile of the weight-for-recumbent-length growth charts. Among children and adolescents aged 2-19 years, 11.9% were at or above the 97th percentile of the body-mass-index-for-age growth charts; 16.9% were at or above the 95th percentile; and 31.7% were at or above the 85th percentile of BMI for age (JAMA 2010;303:242-9).

While more recent reports of obesity in children indicate a modest decline in obesity among 2- to 5-year-olds (JAMA 2014;311:806-14), an alarming number of infants and children have excess adiposity (roughly twice what is expected). In addition, cardiovascular mortality later in life continues to rise.

The question arises, have childhood and adult obesity rates remained high because mothers are feeding their children the wrong foods or because these children were born obese? One also wonders, with respect to cardiovascular mortality in adulthood, is the in utero environment playing a role?

Pages

Recommended Reading

VIDEO: DAWN2 shows need for patient-centered care in diabetes
MDedge Endocrinology
Diabetes education should seek to improve health care literacy
MDedge Endocrinology
FDA approves canagliflozin/metformin combination
MDedge Endocrinology
VIDEO: Future direction for AADE and diabetes education
MDedge Endocrinology
Diabetes, hypertension drive higher CVD risk in blacks and women
MDedge Endocrinology
Sodium controversy: More fuel for the fire
MDedge Endocrinology
New protocol improves diabetic acidosis management in ED
MDedge Endocrinology
Predischarge preparation for diabetes management lowers recidivism
MDedge Endocrinology
Lilly’s insulin glargine tentatively approved, pending patent litigation
MDedge Endocrinology
Type 1 diabetes test gets FDA go-ahead
MDedge Endocrinology

Related Articles